Cargando…
β2-Adrenergic Signalling Promotes Cell Migration by Upregulating Expression of the Metastasis-Associated Molecule LYPD3
Metastasis is associated with poor prognosis in breast cancer. Although some studies suggest beta-blockers increase survival by delaying metastasis, others have been discordant. This study provides both insights into the anomalous findings and identifies potential biomarkers that may be treatment ta...
Autores principales: | Gruet, Michael, Cotton, Daniel, Coveney, Clare, Boocock, David J., Wagner, Sarah, Komorowski, Lucie, Rees, Robert C., Pockley, A. Graham, Garner, A. Christopher, Wallis, John D., Miles, Amanda K., Powe, Desmond G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168268/ https://www.ncbi.nlm.nih.gov/pubmed/32098331 http://dx.doi.org/10.3390/biology9020039 |
Ejemplares similares
-
Biomarker Identification in Breast Cancer: Beta-Adrenergic Receptor Signaling and Pathways to Therapeutic Response
por: Kafetzopoulou, Liana E., et al.
Publicado: (2013) -
Functional interaction between Lypd6 and nicotinic acetylcholine receptors
por: Arvaniti, Maria, et al.
Publicado: (2016) -
Human LYPD8 protein inhibits motility of flagellated bacteria
por: Hsu, Chiao-Ching, et al.
Publicado: (2017) -
LYPD8 regulates the proliferation and migration of colorectal cancer cells through inhibiting the secretion of IL-6 and TNF-α
por: Xu, Jianbin, et al.
Publicado: (2021) -
Heart-derived fibroblasts express LYPD-1 and negatively regulate angiogenesis in rat
por: Sakamoto, Satoru, et al.
Publicado: (2020)